Investor Ares Trading S.A.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ares Trading S.A. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-02-14 13G/A VERA / Vera Therapeutics, Inc. 1,913,501 1,913,501
2024-02-14 13G/A PGEN / Precigen, Inc. 20,647,152 20,647,152
2023-01-27 13G/A PGEN / Precigen, Inc. 20,647,152 20,647,152
2023-01-27 13G/A VERA / Vera Therapeutics, Inc. 1,913,501 1,913,501
2022-01-24 13G/A PGEN / Precigen, Inc. 27,398,519 20,647,152
2022-01-24 13G VERA / Vera Therapeutics, Inc. 1,913,501
2021-01-08 13G/A PGEN / Precigen, Inc. 24,852,348 27,398,519
2020-01-22 13G/A PGEN / Precigen, Inc. 24,080,139 24,852,348
2019-01-07 13G PGEN / Precigen, Inc. 24,080,139
2018-01-22 13G/A OBSV / ObsEva SA. 2,087,303 1,949,303
2017-10-26 13G OBSV / ObsEva SA. 2,087,303